Slaughters and HSF lead on AbbVie’s £30.1bn bid for Shire
Herbert Smith Freehills and Slaughter and May are advising on the proposed takeover of Dublin-based Shire, by US drug manufacturer AbbVie. AbbVie increased its offer by 11 per cent on Tuesday (8 July), from £46.26 a share up to £51.15 – based on a mixture of cash and AbbVie shares. The offer values the company […]